<DOC>
	<DOCNO>NCT00222261</DOCNO>
	<brief_summary>In ASCET study , 1000 patient document coronary heart disease randomize either continue treatment aspirin 160 mg/d change clopidogrel 75mg/d . Clinical endpoint record least 2 year related initial aspirin response , assess PFA-100® method , investigate whether aspirin non-responders higher composite event rate responder whether Clopidogrel treatment patient non-responsive aspirin reduce risk future clinical event . The clinical event composite unstable angina , myocardial infarction , stroke death .</brief_summary>
	<brief_title>Aspirin Non-responsiveness Clopidogrel Endpoint Trial .</brief_title>
	<detailed_description>Background : Aspirin widely use antiplatelet drug patient coronary heart disease . Despite documented clinical benefit , many patient aspirin still experience severe cardiovascular event . Several laboratory report show lack platelet inhibition 5-40 % aspirin-treated patient , term aspirin resistance introduce . The clinical relevance laboratory finding , however , still unknown . New antiplatelet drug develop , adenosin diphosphate ( ADP ) receptor inhibitor clopidogrel least efficacy aspirin acceptable safety profile . Laboratory method determination platelet reactivity treatment efficacy complicate time consume . New methodology , like PFA-100® system , make analysis suitable clinical use . Design : In ASCET study , 1000 patient document coronary heart disease randomize either continue treatment aspirin 160 mg/d change clopidogrel 75mg/d initial determination platelet reactivity aspirin treatment . Clinical endpoint record least 2 year related initial aspirin response . Scand Cardiovasc J . 2004 Dec ; 38 ( 6 ) :353-6 .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Stable , symptomatic coronary heart disease , verify coronary angiography , treat angioplasty/stent implantation ( PCI ) . Indication warfarin treatment . Indication contraindication study drug . Pregnancy breastfeed . Malignancy may interfere life expectancy . Psychiatric disease , mental retardation , dementia , drug abuse , alcoholism condition severely reduce compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>antiplatelet therapy</keyword>
	<keyword>aspirin non-responders</keyword>
	<keyword>aspirin resistance</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>coronary heart disease</keyword>
	<keyword>stable angina pectoris</keyword>
</DOC>